Stay updated on AGEN1884 in Advanced Cancer After PD-1/PD-L1 Clinical Trial
Sign up to get notified when there's something new on the AGEN1884 in Advanced Cancer After PD-1/PD-L1 Clinical Trial page.

Latest updates to the AGEN1884 in Advanced Cancer After PD-1/PD-L1 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry v3.4.2 was added to the history, and older notices including the v3.4.1 funding/operating status message were removed.SummaryDifference0.6%

- Check21 days agoChange DetectedA site-wide funding-status notice was added and the page revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check28 days agoChange DetectedGlossary visibility added and color-coded change indicators (green for additions, red for deletions) are now shown on the history page. The revision label was updated to v3.4.0 and the No FEAR Act data text was adjusted.SummaryDifference0.7%

- Check35 days agoChange DetectedRevision: v3.3.4 appears in the page header, replacing v3.3.3—a minor UI change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 appears and HHS Vulnerability Disclosure and Revision: v3.3.2 are removed from the footer, reflecting minor site maintenance; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page's version history shows the addition of Revision: v3.3.2 and the removal of Revision: v3.3.1, reflecting site version labeling rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AGEN1884 in Advanced Cancer After PD-1/PD-L1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AGEN1884 in Advanced Cancer After PD-1/PD-L1 Clinical Trial page.